Results 241 to 250 of about 21,762 (295)
Some of the next articles are maybe not open access.
Critical Care Clinics, 2005
Botulinum toxin is regarded as the most lethal substance known. It is estimated that the human LD50 for inhalation botulism is 1 to 3 nanograms of toxin/kilogram body mass. Although only three cases of inhalational botulism have been described, an understanding of the pathophysiology of food-borne outbreaks, wound botulism, and infant botulism, and ...
openaire +2 more sources
Botulinum toxin is regarded as the most lethal substance known. It is estimated that the human LD50 for inhalation botulism is 1 to 3 nanograms of toxin/kilogram body mass. Although only three cases of inhalational botulism have been described, an understanding of the pathophysiology of food-borne outbreaks, wound botulism, and infant botulism, and ...
openaire +2 more sources
Clinics in Dermatology, 2003
Botulinum toxin type A (BOTOX, Dysport) has revolutionized treatment of wrinkles around the eyes. Since the first publications of its cosmetic benefit by Drs. Jean and Alastair Carruthers, hundreds of articles have been published about its cosmetic use. BOTOX holds U.S.
openaire +2 more sources
Botulinum toxin type A (BOTOX, Dysport) has revolutionized treatment of wrinkles around the eyes. Since the first publications of its cosmetic benefit by Drs. Jean and Alastair Carruthers, hundreds of articles have been published about its cosmetic use. BOTOX holds U.S.
openaire +2 more sources
International Journal of Food Microbiology, 1990
Abstract Structure, activation, destruction, lethality, genesis, neurotoxic action and medical application of botulinal toxins are reviewed.
openaire +2 more sources
Abstract Structure, activation, destruction, lethality, genesis, neurotoxic action and medical application of botulinal toxins are reviewed.
openaire +2 more sources
American Journal of Physical Medicine & Rehabilitation, 2004
In the United States, the popularity of botulinum toxins as agents to treat muscle hypertonia has grown significantly over the last decade, despite lack of approval from the Food and Drug Administration for the indication of spasticity. Botox (botulinum toxin type A) and Myobloc (botulinum toxin type B) are Food and Drug Administration-approved for ...
openaire +2 more sources
In the United States, the popularity of botulinum toxins as agents to treat muscle hypertonia has grown significantly over the last decade, despite lack of approval from the Food and Drug Administration for the indication of spasticity. Botox (botulinum toxin type A) and Myobloc (botulinum toxin type B) are Food and Drug Administration-approved for ...
openaire +2 more sources
Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics
Nature Reviews Microbiology, 2021Shannon L Kordus, Dana Borden Lacy
exaly